To Homepage

Homogenous Immunoassays: Oncology

Recognize the signs in time in cancer patients

...to keep every place occupied

visual immunoassays oncology 450 300

Contact us >

Confident follow-up in cancer patients

  • Making sure every change in the marker is coming from the disease and not caused by the imprecision of the Analyzers or by interfering substances
  • Excellent precision for optimal patient follow-up and confident decision
  • Broad tumor marker portfolio available

More about B∙R∙A∙H∙M∙S tumor markers >

Not all products are CE marked or have 510(k) clearance for sale in the U.S. Availability of products in each country depends on local regulatory marketing authorization status.